Literature DB >> 21486700

Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adults.

Jan Komorowski1, Joanna Jankiewicz-Wika, Krzysztof Kolomecki, Jacek Cywinski, Katarzyna Piestrzeniewicz, Jacek Swiętoslawski, Henryk Stepien.   

Abstract

BACKGROUND: Obesity is associated with endothelial dysfunction and increased inflammation as well as with expansion of the capillary bed in regional adipose deposits, and a balance between these factors is involved in angiogenesis. Osteopontin (OPN) is a proinflammatory cytokine involved in regulating immune processes and mediating chronic inflammation. Its level is usually elevated in the plasma and adipose tissue of obese subjects. E-selectin, an adhesion molecule which is released by dysfunctional endothelial cells, is believed to be a marker of an early atherosclerotic process. Endostatin (END), an angiogenesis inhibitor, is present in the blood of obese subjects. The most effective treatment to achieve weight loss in morbidly obese subjects is bariatric surgery. The aim of the study was to evaluate and compare the circulating concentrations of OPN, E-selectin and END as well as the insulin resistance (HOMA-IR) of severely obese patients with metabolic syndrome before and after vertical banded gastroplasty (VBG).
MATERIAL AND METHODS: The test cohorts comprised eight males and 20 females (total 28 patients) aged from 20 to 59 years with simple obesity and the presence of metabolic syndrome, both before and 3, 6, 12, 24 months after bariatric surgery (six patients were also checked after 36 and four after 48 months).
RESULTS: Bariatric surgery significantly reduced (over 24 months) body weight, BMI, waist circumference, HOMA-IR and blood concentrations of CRP. Plasma OPN gradually increased after VBG and E-selectin in systemic blood decreased. We did not observe any differences in END concentrations from 12 to 48 months after surgery.
CONCLUSION: VBG improves metabolic syndrome parameters, decreases E-selectin and gradually increases OST blood concentrations but it does not have any significant influence on END levels.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21486700     DOI: 10.1016/j.cyto.2011.03.020

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Effect of sleeve gastrectomy on osteopontin circulating levels and expression in adipose tissue and liver in rats.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

2.  Vascular adhesion molecules in men with obstructive sleep apnea: associations with obesity and metabolic syndrome.

Authors:  Guoda Pilkauskaite; Skaidrius Miliauskas; Astra Vitkauskiene; Raimundas Sakalauskas
Journal:  Sleep Breath       Date:  2014-02-25       Impact factor: 2.816

Review 3.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 4.  Effect of Surgically Induced Weight Loss on Biomarkers of Endothelial Dysfunction: a Systematic Review and Meta-Analysis.

Authors:  Javad Seyyedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2020-09       Impact factor: 4.129

5.  The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.

Authors:  Z A Yegin; Ö T İyidir; C Demirtaş; E Suyanı; İ Yetkin; H Paşaoğlu; Ç İlhan; G T Sucak
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

6.  Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; María J Gil; Fernando Rotellar; Secundino Fernández; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Surg Endosc       Date:  2014-03-13       Impact factor: 4.584

7.  Inflammatory markers and bariatric surgery: a meta-analysis.

Authors:  S Raghavendra Rao
Journal:  Inflamm Res       Date:  2012-05-16       Impact factor: 4.575

Review 8.  Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

Authors:  Florian Kahles; Hannes M Findeisen; Dennis Bruemmer
Journal:  Mol Metab       Date:  2014-03-22       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.